Combined modality treatment with accelerated radiotherapy and chemotherapy in patients with locally advanced inoperable carcinoma of the pancreas: Results of a feasibility study

British Journal of Cancer

Volumn 75, Issue 4, 1997, Pages 597-601

  Prott, F J ^a   Schonekaes K ^a   Preusser, P ^a   Ostkamp, K ^a   Wagner, W ^a   Micke, O ^a   Potter R ^b   Sulkowski, U ^a   Rube C ^a   Berns, T ^a   Willich, N ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

5 fluorouracil; Folinic acid; Pancreatic cancer; Radiochemotherapy

Indexed keywords

FLUOROURACIL; FOLIC ACID DERIVATIVE; FOLINIC ACID; PYRIMIDINE ANTAGONIST;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DIARRHEA; FEASIBILITY STUDY; FEMALE; HUMAN; HUMAN TISSUE; INTRAVENOUS DRUG ADMINISTRATION; LEUKOPENIA; MALE; MUCOSA INFLAMMATION; MULTIMODALITY CANCER THERAPY; NAUSEA; PANCREAS ADENOCARCINOMA; PRIORITY JOURNAL; RADIATION DOSE; THROMBOCYTOPENIA; VOMITING;

EID: 8044245922     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1997.104     Document Type: Article

References (29)

1. Arbuck SG (1990) Chemotherapy for pancreatic cancer. Baillieres Clin Gastroenterol 4: 953-968
2. Ardalan B, Ucar A, Reddy R, Livingstone AS, Markoe A, Schwade J, Richman SP and Donofrio K (1994) Phase I trial of low dose N-phosphonacetyl-I-aspartic acid and high dose 5-fluorouracil administered concomitantly with radiation therapy for unresectable localized adenocarcinoma of the pancreas. Cancer 74: 1869-1873
3. Boz G, De-Paoli A, Roncadin M, Franchin G, Galligioni E, Arcicasa M, Bortolus R, Gobitti C, Minatel E and Innocente R (1991) Radiation therapy combined with chemotherapy for inoperable pancreatic carcinoma. Tumori 77: 61-64
4. Brennan MF, Kinsella T and Friedman M (1989) Cancer of the Pancreas. In Cancer - Principles and Practice of Oncology, De Vita VT, Hellman S and Rosenberg SA. (eds), pp. 888-835. Lippincott: Philadelphia.
5. Bronn D, Franklin R and Krishnan R (1995) Rapid radiographic response in pancreatic cancer with concurrent continuous infusion of 5- fluorouracil and cis-platin and hyperfractionated radiotherapy. Proc ASCO 14: 193
6. Conrath SM (1986) The use of epidemiology, scientific data, and regulatory authority to determine risk factors in cancers of some organs of the digestive system. 6. Pancreatic cancer. Regul Toxicol Pharmacol 6: 193-210
7. Conrath SM (1987) The validity of determining pancreatic cancer incidence in the United States by the use of mortality data. Regul Toxicol Pharmacol 7: 43-56
8. Creaven PJ, Petrelli NJ and Rustum YM (1989) Leucovorin/5-fluorouracil: response and toxicity in relation to quality of life. In Leucovorin Modulation of Fluoropyrimidines: A New Frontier in Cancer Chemotherapy, Pinedo HM and Rustum JM (eds), pp. 57-64 Royal Society of Medicine Services: London.
9. Cubilla AL, Fitzgerald PJ and Fortner JG (1978) Pancreas cancer - duct cell adenocarcinoma: survival in relation to site, size, stage and type of therapy. J Surg Oncol 10: 465-482
10. Cubilla AI and Fitzgerald PJ (1979) Classification of pancreatic cancer (nonendocrine). Mayo Clin Proc 54: 449-458
11. De Rooij PD, Rogatko A and Brennan MF (1991) Evaluation of palliative surgical procedures in unresectable pancreatic cancer. Br J Surg 78: 1053-1058
12. Decarpio JA, Arbuck SG and Mayer RJ (1989) Phase II study of weekly 5-fluorouracil (5-FU) and folinic acid (FA) in previously untreated patients with unresectable measurable pancreatic adenocarcinoma. Proc Am Soc Clin Onc 8: 100
13. Dobelbower RR and Bronn DG (1990) Radiotherapy in the treatment of pancreatic cancer. Baillieres Clin Gastroenterol 4: 969-983
14. Dobelbower RR, Merrick HW, Ahuja RK and Skeel RT (1986) 1251 interstitial implant, precision high-dose external beam therapy, and 5-FU for unresectable adenocarcinoma of pancreas and extrahepatic biliary tree. Cancer 58: 2185-2195
15. Isacoff WH, Reber H, Tompkins R, Zinner MJ, Brody M, Quilici P and Taylor O (1995) Continuous infusion (CI) 5-Fluoururacil (5-FU), Calcium Leucovorin (LV), Mitomycin-C (Mito C) and Dipyridamole (D): treatment for patients with locally advanced pancreatic cancer. Proc ASCO 14: 198
16. Jeckel J and Treuniert-Donker AD (1991) Treatment perspectives in locally advanced unresectable pancreatic cancer. Br J Surg 78: 1332-1334
17. Machover D, Schwarzenberg L and Goldschmitt E (1982) Treatment of advanced colorectal and gastric adenocarcinoma with 5-fluoruracil and high dose folinic acid. Cancer 66: 1803-1807
18. Montemaggi P, Dobelbower R, Crucitti F, Caracciolo F, Morganti AG, Smaniotto D, Luzi S and Cellini N (1991) Interstitial brachytherapy for pancreatic cancer: report of seven cases treated with 1251 and a review of the literature. Int J Radiat Oncol Biol Phys 21: 451-457
19. Russell RCG (1990) Surgical resection for cancer of the pancreas. Baillieres Clin Gastroenterol 4: 889-916
20. Schuster Uitterhoeve AL, Gonzalez Gonzalez D and Blank LE (1986) Radiotherapy with multiple fractions per day in pancreatic and bile duct cancer. Radiother Oncol 7: 205-213
21. Seydel G, Stablein DM, Leichman LP, Kinzie JJ and Thomas PRM (1990) Hyperfractionated radiation and chemotherapy for unresectable localized adenocarcinoma of the pancreas. Cancer 65: 1478-1482
22. Shibamoto Y, Manabe T, Baba N, Sasai K, Takahashi M, Tobe T and Abe M (1990) High dose, external beam and intraoperative radiotherapy in the treatment of resectable and unresectable pancreatic cancer. Int J Radiat Oncol Biol Phys 19: 605-611
23. Tannapfel A, Wittekind C and Hünefeld G (1992) Ductal adenocarcinoma of the pancreas Int J Pancreatol 12: 145-152
24. Tepper JE, Shipley WU, Warshaw AL, Nardi GL, Wood WC and Orlow EL (1987) The role of misonidazole combined with intraoperative radiation therapy in the treatment of pancreatic carcinoma. J Clin Oncol 5: 579-584
25. Tepper JE, Noyes D, Krall JM, Sause WT, Wolkov HB, Dobelbower RR, Thomson J, Owens J and Hanks GE (1991) Intraoperative radiation therapy of pancreatic carcinoma: a report of RTOG-8505. Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys 21: 1145-1149
26. The Gastrointestinal Tumor Study Group (1981) Therapy of locally unresectable pancreatic carcinoma: a randomized comparison of high dose (6000 rads) radiation alone, moderate dose radiation (4000 rads + 5-fluorouracil), and high dose radiation + 5-fluorouracil. Cancer 48: 1705-1710
27. Wagener DJT, Hoesel QGCM and Van Yap SH (1989) Phase II trial of 5-fluorouracil. adriamycin and cisplatin (FAP) followed by radiation and 5-FU in locally advanced pancreatic cancer Cancer Chemoth Phamacol 25: 131-134
28. Wagener DJT, DE Mulder PHM and Wils JA (1994) Multimodality treatment of locally advanced pancreatic cancer Ann Oncol 3: 81-86
29. Whittington R, Neuberg D, Tester WJ, Benson AB III and Haller DG (1995) Protracted intravenous fluorouracil infusion with radiation therapy in the management of locallized pancreaticobilliary carcinoma: a phase I Eastern Cooperative Oncology Group Trial. J Clin Oncol 13: 227-232